Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
Md. Sahab Uddin, Abdullah Al Mamun, Dewan Md. Sumsuzzman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 99
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics
Mauro Alini, Ashish D. Diwan, W. Mark Erwin, et al.
JOR Spine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 28
Cannabinoids modulate the microbiota–gut–brain axis in HIV/SIV infection by reducing neuroinflammation and dysbiosis while concurrently elevating endocannabinoid and indole-3-propionate levels
Marina McDew‐White, Eun-Hee Lee, Lakmini S. Premadasa, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4379-4402
Open Access | Times Cited: 9
Green Synthesis, Characterization, and Antibacterial Properties of Silver Nanoparticles Obtained by Using Diverse Varieties of Cannabis sativa Leaf Extracts
Adriana Cecilia Csakvari, Cristian Moisă, Dana Radu, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4041-4041
Open Access | Times Cited: 45
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 6
Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
Ziyad M. Althafar
Molecules (2022) Vol. 27, Iss. 13, pp. 4124-4124
Open Access | Times Cited: 25
Δ8-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis
Agnese Gugliandolo, Santino Blando, Stefano Salamone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6598-6598
Open Access | Times Cited: 15
Mechanisms of comorbidity between Alzheimer's disease and pain
Kaifang Yao, Shenjun Wang, Zhifang Xu, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease
Marina Šagud, Lucija Tudor, Nela Pivac
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 5, pp. 571-589
Closed Access | Times Cited: 23
Butyrylcholinesterase inhibitors as potential anti-Alzheimer’s agents: an updated patent review (2018-present)
José G. Fernández‐Bolaños, Óscar López
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 8, pp. 913-932
Closed Access | Times Cited: 17
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 955-971
Closed Access | Times Cited: 3
Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
Newman Osafo, Oduro Kofi Yeboah, Aaron Opoku Antwi
Molecular Biology Reports (2021) Vol. 48, Iss. 4, pp. 3665-3680
Closed Access | Times Cited: 22
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials
Magham Sai Varshini, Praveen Thaggikuppe Krishnamurthy, Neenu Shaji, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 11, pp. 2888-2905
Closed Access | Times Cited: 19
Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
Taesic Lee, Hyunju Lee
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1525-1525
Open Access | Times Cited: 18
Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer’s Disease
Nishat Malik, Sanila Amber, Saadia Zahid
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Cannabinerol Prevents Endoplasmic Reticulum and Mitochondria Dysfunctions in an In Vitro Model of Alzheimer’s Disease: A Network-Based Transcriptomic Analysis
Luigi Chiricosta, Aurelio Minuti, Agnese Gugliandolo, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1012-1012
Open Access | Times Cited: 2
The Effects of Chronic Marijuana Administration on 6-OHDA-Induced Learning & Memory Impairment and Hippocampal Dopamine and Cannabinoid Receptors Interaction in Male Rats
Elham Haghparast, Vahid Sheibani, Gholamreza Komeili, et al.
Neurochemical Research (2023) Vol. 48, Iss. 7, pp. 2220-2229
Closed Access | Times Cited: 6
An Optimized Terpene Profile for a New Medical Cannabis Oil
Valentina Maggini, Lorenzo Calvi, Tommaso Pelagatti, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 298-298
Open Access | Times Cited: 10
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
Paula Morales, Chanté Muller, Nadine Jagerovic, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 10
Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
Laura Boullon, Raquel Abalo, Alvaro Llorente‐Berzal
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11
Cannabinoids in anesthesia and chronic pain: Where do we stand?
Khushboo Pandey, Wasimul Hoda
Saudi Journal of Anaesthesia (2024) Vol. 18, Iss. 1, pp. 100-104
Open Access
Temporomandibular joint dysfunction syndrome – a therapeutic approach
Călin Florin Bochiș, Manuela Simona Pop, Sergiu Alin Bochiș, et al.
Balneo and PRM Research Journal (2023) Vol. 14, Iss. Vol.14, no.2, pp. 546-546
Open Access | Times Cited: 1
Espécies vegetais de uso popular no tratamento da dor: uma revisão sistemática
Ana Catharinny da Silva de Oliveira, Nilson de Jesus Pereira Batalha Júnior, Ana Paula Muniz Serejo, et al.
Research Society and Development (2022) Vol. 11, Iss. 2, pp. e22511225608-e22511225608
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top